Farah Huzair
Biographic Data
| ID | 6698998 |
|---|---|
| NAME | Farah Huzair |
| GIVEN NAMES | Farah |
| FAMILY NAME | Huzair |
| SIGNATURE | HUZAIR F |
| AFFILIATIONS | University of Edinburgh |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 3 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2008 |
| LATEST PUBLICATION YEAR | 2017 |
| H-INDEX | 1 |
Biotechnology and the transformation of vaccine innovation
The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system. In this paper, we show how the early development of the hepatitis B vaccines was shaped by a political and economic context that newly favoured commercialisation of academic research, including the appropriation and management of intellectual property; we elucidate the…
Life Sciences Innovation in Central and Eastern Europe
This article outlines analytical frameworks for studying life sciences innovation in Central and Eastern Europe (CEE), based on national systems of innovation and the triple helix. The reflexive and evolutionary models of triple helix 1-3 help us in evaluating life sciences innovation in the shift from pre- to post-transition, and are useful in providing a systemic approach that emphasises social institutions over the role of the firm. While pre-…
Innovative Potential in Hungarian Agricultural Biotechnology and the Evolution of Networks
The ban on commercial GMO cultivation in Hungary suggests a scenario in which scientific progress may decline and innovative potential may thus deteriorate. There is the added difficulty of greatly reduced funding and the loss of expertise that accompany fiscal austerity measures. However, initial findings from recent fieldwork suggest that science and innovative potential have not been 'stopped in their tracks.' This paper demonstrates how innov…
Biotechnology and the transformation of vaccine innovation
The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system. In this paper, we show how the early development of the hepatitis B vaccines was shaped by a political and economic context that newly favoured commercialisation of academic research, including the appropriation and management of intellectual property; we elucidate the…
Life Sciences Innovation in Central and Eastern Europe
This article outlines analytical frameworks for studying life sciences innovation in Central and Eastern Europe (CEE), based on national systems of innovation and the triple helix. The reflexive and evolutionary models of triple helix 1-3 help us in evaluating life sciences innovation in the shift from pre- to post-transition, and are useful in providing a systemic approach that emphasises social institutions over the role of the firm. While pre-…
Innovative Potential in Hungarian Agricultural Biotechnology and the Evolution of Networks
The ban on commercial GMO cultivation in Hungary suggests a scenario in which scientific progress may decline and innovative potential may thus deteriorate. There is the added difficulty of greatly reduced funding and the loss of expertise that accompany fiscal austerity measures. However, initial findings from recent fieldwork suggest that science and innovative potential have not been 'stopped in their tracks.' This paper demonstrates how innov…
Biotechnology and the transformation of vaccine innovation
The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system. In this paper, we show how the early development of the hepatitis B vaccines was shaped by a political and economic context that newly favoured commercialisation of academic research, including the appropriation and management of intellectual property; we elucidate the…
Business (3 works) · Economics (3 works) · Political science (3 works) · Bioeconomy and Sustainability Development (2 works) · Biology (2 works) · Economic system (2 works) · Management (2 works) · Adaptability (1 work) · Adaptation (eye (1 work) · Agricultural biotechnology (1 work)